PR
Payden & Rygel Portfolio holdings
AUM
$1.21B
This Quarter Return
-1.03%
1 Year Return
+22.56%
3 Year Return
+69.35%
5 Year Return
+153.64%
10 Year Return
+299.98%
AUM
$1.93B
AUM Growth
+$1.93B
(-8.1%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-7.11%
Top 10 Holdings %
Top 10 Hldgs %
21.78%
Holding
141
New
15
Increased
29
Reduced
45
Closed
14
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$22M |
| 2 |
Mondelez International
MDLZ
|
$21.5M |
| 3 |
Target
TGT
|
$20.3M |
| 4 |
CVS Health
CVS
|
$20M |
| 5 |
Archer Daniels Midland
ADM
|
$19.8M |
Top Sells
| 1 |
Exxon Mobil
XOM
|
$34.6M |
| 2 |
Dover
DOV
|
$33.7M |
| 3 |
Starbucks
SBUX
|
$32.9M |
| 4 |
Valero Energy
VLO
|
$27.1M |
| 5 |
Qualcomm
QCOM
|
$25.9M |
Sector Composition
| 1 | Financials | 20.45% |
| 2 | Healthcare | 17.89% |
| 3 | Technology | 11.22% |
| 4 | Consumer Staples | 10.63% |
| 5 | Consumer Discretionary | 7.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Comcast
CMCSA
$125B
| $49.2M | 2.55% | 879,465 -1,900 | -0.2% | -$106K |
|
2
JPMorgan Chase
JPM
$829B
| $47.3M | 2.46% | 289,056 -4,200 | -1% | -$688K |
|
3
Goldman Sachs
GS
$226B
| $44M | 2.29% | 116,510 -18,700 | -14% | -$7.07M |
|
|
4
CVS Health
CVS
$92.8B
| $43.7M | 2.27% | 514,579 +235,300 | +84% | +$20M |
|
5
Morgan Stanley
MS
$240B
| $43.3M | 2.25% | 445,000 -112,100 | -20% | -$10.9M |
|
|
6
Bristol-Myers Squibb
BMY
$96B
| $42.4M | 2.2% | 716,160 +371,460 | +108% | +$22M |
|
7
Bank of America
BAC
$376B
| $39.3M | 2.04% | 926,190 -154,400 | -14% | -$6.55M |
|
8
Visa
V
$683B
| $39.2M | 2.03% | 176,000 +69,600 | +65% | +$15.5M |
|
9
Merck
MRK
$210B
| $36.1M | 1.87% | 480,510 +58,900 | +14% | +$4.42M |
|
10
SPDR S&P 500 ETF Trust
SPY
$658B
| $35.3M | 1.83% | 82,308 +3,450 | +4% | +$1.48M |
|
11
Williams Companies
WMB
$70.7B
| $34.7M | 1.8% | 1,337,570 +6,070 | +0.5% | +$157K |
|
12
Eli Lilly
LLY
$657B
| $34.6M | 1.8% | 149,725 +32,500 | +28% | +$7.51M |
|
13
Citigroup
C
$178B
| $33.2M | 1.72% | 473,642 -177,900 | -27% | -$12.5M |
|
14
Abbott
ABT
$231B
| $33.2M | 1.72% | 280,630 | – | – |
|
15
Walmart
WMT
$774B
| $32.8M | 1.7% | 235,050 -800 | -0.3% | -$112K |
|
16
Coca-Cola
KO
$297B
| $32.5M | 1.69% | 619,270 -2,100 | -0.3% | -$110K |
|
17
NextEra Energy, Inc.
NEE
$148B
| $32.3M | 1.68% | 411,200 -1,300 | -0.3% | -$102K |
|
18
PepsiCo
PEP
$204B
| $32.2M | 1.67% | 213,900 +47,300 | +28% | +$7.11M |
|
19
Honeywell
HON
$139B
| $31.1M | 1.61% | 146,400 -4,700 | -3% | -$998K |
|
20
AbbVie
ABBV
$372B
| $30.3M | 1.57% | 280,950 +89,150 | +46% | +$9.62M |
|
21
Emerson Electric
EMR
$74.3B
| $30.2M | 1.56% | 320,100 -138,900 | -30% | -$13.1M |
|
22
Texas Instruments
TXN
$184B
| $29.2M | 1.52% | 152,132 -400 | -0.3% | -$76.9K |
|
23
Amgen
AMGN
$155B
| $28.9M | 1.5% | 135,840 +3,800 | +3% | +$808K |
|
24
Prologis
PLD
$106B
| $28.8M | 1.5% | 230,000 -2,600 | -1% | -$326K |
|
25
Microsoft
MSFT
$3.77T
| $27.9M | 1.45% | 98,830 -1,200 | -1% | -$338K |
|